WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Online Marketing Friday, November 16, 2018 
Add Press Release News | News Feeds Feeds | Email This News Email


The Global Tumor Ablation Market is Anticipated to Reach $2.16 Billion by 2025, Expanding at a CAGR of 11.12%
Friday, November 09, 2018

DUBLIN, Nov 9, 2018 /PRNewswire/ --

The "Tumor Ablation Market Size, Share & Trends Analysis Report By Treatment (Surgical, Laparoscopic), By Technology (Radiofrequency, Microwave, Cryoablation), By Application, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The global tumor ablation market size is anticipated to reach USD 2.16 billion by 2025. It is expected to expand at a CAGR of 11.12% over the forecast period.

High prevalence of cancer across the globe is the key market driver. About 13% of population suffers from cancer each year, as per the statistics by the World Health Organization (WHO). Extensive adoption of minimally invasive procedures due to the benefits such as less trauma, speedy recovery, and faster recovery is anticipated to bode well for market expansion.

Increasing demand for minimally invasive surgeries coupled with technological advancements in thermal ablation is anticipated to boost market growth. For instance, Usage of cooled radiofrequency denervation technique-a procedure that uses radiofrequency thermal energy to ablate sensory nerve fibers of the sacroiliac joint-with internally cooled radiofrequency probes to enlarge size of the lesion. Similarly, in February 2015, SonaCare Medical LLC launched Sonalink-a remote patient monitoring platform-that can be used during HIFU procedures.

In addition, rising per capita income is enabling people to opt for advanced treatment for tumors. This factor is anticipated to positively influence market growth over the forecast period. Active role of healthcare agencies and government in creating awareness about various cancer types is expected to facilitate usage of tumor ablation therapy.

Further key findings from the study suggest:

    --  Radiofrequency emerged as the dominant technology segment with 30.5%
        share in 2016 attributed to application in removal of solid tumors
    --  Percutaneous procedures are expected to witness lucrative growth over
        the forecast period due to rising demand for minimally invasive
        procedures offering faster recovery and higher safety
    --  Lung cancer is anticipated to witness substantial growth owing to high
        prevalence caused by sedentary lifestyle, rise in smoking, and air
        pollution
    --  North America dominated the overall market in the past due to high
        prevalence of cancer in Canada, high purchasing power parity, government
        support for quality healthcare, and availability of reimbursement
    --  Major players operating in the tumor ablation market include, Galil
        Medical Inc.; Misonix Inc.; HealthTronics, Angiodynamics; Boston
        Scientific Corporation; Medtronic Plc. (Covidien); SonaCare Medical;
        EDAP TMS S.A.; and Neuwave Medical Inc

Topics Covered

Chapter 1 Executive Summary

Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Data Analysis
2.3 Region Wise Market Calculation
2.3.1 Region Wise Market: Base Estimates
2.3.2 Global Market: CAGR Calculation
2.4 Region based segment share calculation
2.5 List of Secondary Sources (partial list)
2.6 Market Snapshot

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Rising incidence of cancer
3.2.2 Technological advancements in ablation devices
3.2.3 Increasing per capita income
3.2.4 Growing demand of minimally invasive surgeries
3.3 Market Restraint Analysis
3.3.1 Complications associated with Tumor Ablation therapy
3.3.2 Stringent regulations & approvals
3.4 Penetration & Growth Prospect Mapping: Product
3.5 Tumor Ablation Market c SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis - Porter's

Chapter 4 Tumor Ablation Market: Technology Estimates & Trend Analysis
4.1 Tumor ablation market: Technology movement analysis
4.2 Radiofrequency ablation
4.3 Microwave ablation
4.4 Cryoablation
4.5 Irreversible electroporation
4.6 Other ablation technologies

Chapter 5 Tumor Ablation Market: Treatment Estimates & Trend Analysis
5.1 Tumor Ablation market: Treatment movement analysis
5.2 Surgical ablation
5.3 Laparoscopic ablation
5.4 Percutaneous ablation

Chapter 6 Tumor Ablation Market: Application Estimates & Trend Analysis
6.1 Tumor Ablation market: Application movement analysis
6.2 Liver cancer
6.3 Breast cancer
6.4 Lung cancer
6.5 Prostate cancer
6.6 Other cancer

Chapter 7 Market Share Analysis
7.1 Market share analysis: HIFU competitive analysis

Chapter 8 Regional Estimates & Trend Analysis, by Technology, Treatment, & Application
8.1 Tumor ablation market share by region, 2017 & 2025
8.2 North America
8.3 Europe
8.4 Asia Pacific
8.5 Latin America
8.6 Middle East & Africa

Chapter 9 Competitive Landscape

9.1 Company Profiles9.1.1 Medtronic

9.1.2 AngioDynamics

9.1.3 Mermaid Medical

9.1.4 HealthTronics, Inc.

9.1.5 Galil Medical, Inc.

9.1.6 EDAP TMS

9.1.7 Boston Scientific Corporation

9.1.8 SonaCare Medical LLC

9.1.9 Misonix

9.1.10 NeuWave Medical, Inc.

9.1.11 ERBE Elektromedizin GmbH

9.1.12 Biotronik



For more information about this report visit https://www.researchandmarkets.com/research/skd435/the_global_tumor?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/the-global-tumor-ablation-market-is-anticipated-to-reach-2-16-billion-by-2025--expanding-at-a-cagr-of-11-12-300747434.html

SOURCE Research and Markets



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav Arcis Golf Properties Honored Among "Best" By Avid Golfer Magazine Cowboys Golf Club No. 1 Overall Golf Club In DFW Region for 17th Year in a Row | Nov 16, 2018
Nav 1787fp Named Top 10 Wealth Management Technology Solution Providers for 2018 by Banking CIO Outlook | Nov 16, 2018
Nav American IRA Discusses How to Understand UBTI in a Self-Directed IRA | Nov 16, 2018
Nav Media Place Partners Announces Record Agency Growth | Nov 16, 2018
Nav SINA Corporation to Report Third Quarter 2018 Financial Results on November 28, 2018 | Nov 16, 2018
Nav Cognizant to Webcast Investor Day Today | Nov 16, 2018
Nav There Are More Ways to Market a Business Than With Just Advertisements, Says Brandon Frere | Nov 16, 2018
Nav Digital Marketing Company, fishbat, Shares 4 Reasons Images Help to Increase Engagement | Nov 16, 2018
Nav Demandbase Included On Deloitte's 2018 Technology Fast 500(TM) Fastest Growing Company In North America | Nov 15, 2018
Nav The9 Limited to Hold Annual General Meeting on December 17, 2018 | Nov 15, 2018
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News